4Song W, Jeong SH, Kim JS, et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp. , Salmonella spp. , and Proteus mirabilis. Diagn Microbial Infect Dis ,2007,57:315-318.
6Seifert H, Dolzani L, Bressan R, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Mierobiol,2005 ,43 :4328-4335.
7Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial, 1995,33:2233-2239.
8Wang H, Kelkar S, Wu W, et al. Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX~M-3 at a hospital in China. Antimicrob Agents Chemother, 2003,47 : 790 -793.
4Bamaud G, Arlet G, Verdet C, et al. Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii[ J ]. Antimicrob Agents Chemother, 1998,42 :2352-2358.
5Bauernfeind A, Stemplinger I, Jungwirth R, et al.Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance [J ]Antimicrob Aagents Chemother, 1996,40:221-224.
6Bou G, Oliver A, Ojeda M, et al. Molecular Characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia Coli strain isolated in Spain[J]. Antimicrob Agents Chemother, 2000,44:2549-2553.
7Bradford A, Urban C, Mariano N, et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein[J ]. Antimicrob Agents Chemother, 1997, 41: 563-569.
8Fosberry P, Payne J, Lawlor E, et al. Cloning and sequence analysis of blaBIL-l, a plasmid-mediated class C beta-lactamase gene in Escherichia coil BS[J]. Antimicrob Agents Chemother, 1994,38.1182-1185.
9Gazouli M, Tzouvelekis L, Prinarakis E, et al. Transferable cefoxitin resistance in enterobacteria from greek hospital and characterization of a plasmid-mediatedgroup 1 beta-lactamase(LAT-2) [J ]. Antimicrob Agents Chemother, 1996,40:1736-1740.
10Girlich D, Naas T, Bellais S, et al. Heterogeneity of AmpC cephalosporinases of hafnia alvei clinical isolates expressing. Inducible or constitutive ceftazidime resistance phenotypes [ J ]. Antimicrob Agents Chemother,2000,44 : 3220-3223.
